Delivery Order SPE2DE21D0029-SPE2D625F1BKK
- Not listed
- Becton, Dickinson and Company (BD), through its Infectious Diseases Systems (IDS) division, received a delivery order valued at $1,786.65 from the Department of Defense's Medical Supply Chain on July 31, 2025. The contract is a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, reflecting BD's competitive standing as a large medical technology manufacturer. Performance will be completed by August 21, 2025, at BD's facility in Sparks Glencoe,...
- Becton, Dickinson and Company's Diagnostic Systems (IDS) division has been awarded a delivery order valued at $1,786.65 by the Department of Defense's Medical Supply Chain division for performance in Sparks Glencoe, Maryland. This fixed-price delivery order with economic price adjustment provisions was awarded on July 22, 2025, with an ultimate completion date of August 12, 2025. The contract utilizes no small business set-aside designation, reflecting BD's competitive position as a large,...
- Becton, Dickinson and Company (BD), through its Diagnostic Systems division, was awarded a delivery order valued at $3,402.60 by the Department of Defense's Medical Supply Chain on July 17, 2025, for the Kit Affirm VPIII Clinical. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of August 7, 2025, and will be performed in Sparks Glencoe, Maryland. The award was made on a full and open competition basis without set-aside designation, consistent...
- The U.S. Department of Defense Medical Supply Chain awarded a $3,573.30 fixed-price delivery order to Becton, Dickinson and Company (BD), Infectious Disease Systems division, on September 5, 2025, with an ultimate completion date of September 26, 2025. This delivery order was issued without a set-aside designation and represents a task order under BD's existing federal contract vehicles. The work will be performed at BD's facility in Sparks Glencoe, Maryland. BD, a global medical technology...
- Becton, Dickinson and Company (BD) was awarded a firm fixed-price delivery order valued at $1,236.90 by the Defense Health Agency's Medical Supply Chain organization on June 2, 2025, with an ultimate completion date of June 5, 2025. The contract, which carries no small business set-aside designation, is for delivery to Franklin Lakes, New Jersey. As a globally recognized medical technology manufacturer, BD specializes in providing sophisticated medical devices, diagnostic products, and...
- On July 30, 2025, the Defense Department's Medical Supply Chain awarded a delivery order valued at $1,458.60 to Becton, Dickinson and Company (BD), IDS Division, for the procurement of 100 units of an affirmation attachment system kit. The contract utilizes fixed-price pricing with economic price adjustment provisions and carries an ultimate completion date of August 20, 2025. Performance will take place at BD's facility in Sparks Glencoe, Maryland. This delivery order was issued without a...
- Becton, Dickinson and Company (BD), through its Diagnostic Systems division, was awarded a delivery order valued at $104.3K by the Defense Health Agency for microbiology identification cards and antimicrobial susceptibility testing analyzer equipment and consumables. The order was issued as a firm fixed price contract with an ultimate completion date of September 30, 2030, and was awarded on a full and open competition basis without set-aside designation. The delivery order is issued under...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $565,008.73 to Becton, Dickinson and Company (BD), a manufacturer of medical devices, instruments, and supplies. The contract, which has an ultimate completion date of October 30, 2023, is for the provision of various medical products classified as "OTHER MEDICAL." This award is not associated with any set-aside program. BD has received numerous federal contracts and...
- Becton, Dickinson and Company's Infectious Diseases Systems division received a delivery order valued at $1,361.04 for the KIT AFFIRM VPIII CLINICAL from the Defense Health Agency's Medical Supply Chain division. Awarded on September 8, 2025, with an ultimate completion date of September 29, 2025, this fixed-price delivery order with economic price adjustment carries no set-aside designation. The work will be performed in Sparks Glencoe, Maryland. This delivery order represents a task order...
- Becton, Dickinson and Company (BD), a global medical technology manufacturer, was awarded a delivery order contract valued at $8,883.00 by the Defense agency's Medical Supply Chain organization. The contract, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, calls for the delivery of sterile, graduated syringes (10mL) with luer lock connectors that are DEHP-free and nitrogen-purged. The contract utilizes firm fixed pricing and does not include a small business...
- SPE2DE21D0029Indefinite Delivery Contract
- SPE2DE21D0029-SPE2D625F1BKKDelivery Order
Becton, Dickinson and Company (BD), through its Diagnostic Systems division, received a delivery order award from the Defense Department's Medical Supply Chain on August 15, 2025, valued at $3,573.30 with a fixed-price contract structure that includes economic price adjustment provisions. The delivery order, which concludes on September 8, 2025, represents a task order issued under a larger indefinite delivery/indefinite quantity contract or blanket purchase agreement. BD's Diagnostic Systems division will perform work at the company's facility in Sparks Glencoe, Maryland. The award was made on a full and open competition basis without small business set-aside designation, reflecting BD's established competitive position as a major medical technology supplier to federal agencies. BD is a globally recognized medical technology manufacturer specializing in diagnostic equipment, laboratory instruments, medical devices, and testing reagents. The company maintains a substantial federal contract portfolio across the Department of Defense, Department of Veterans Affairs, National Institutes of Health, and other health-focused agencies. BD's federal deliverables typically include blood culture systems, microbiology analyzers, molecular testing kits, flow cytometry instruments, and associated reagents and consumables. The company holds multiple significant indefinite delivery vehicles across federal agencies, including a $30 million multiple-award Federal Supply Schedule contract with the VA and a $7 million Blanket Purchase Agreement with the Defense Health Agency, positioning it as a primary supplier of diagnostic medical technologies to the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/15/25 |